Fort Lauderdale – – September 08, 2026 -- KIC Ventures issued a corporate clarification confirming that the U.S. Department of Justice dismissed all criminal charges against portfolio company SpineFrontier Inc. on January 17, 2025, and that no current KIC Ventures portfolio company faces ongoing DOJ litigation tied to the matter.

Fort Washington, Pa. – September 08, 2026 -- ECRI, a global authority on healthcare safety and quality, has appointed Professor Najmedin Meshkati, PhD, to its Board of Trustees, bringing nearly four decades of complex-systems safety research from aviation, nuclear power, and petrochemical operations to the nonprofit's patient safety mission.

Shanghai – September 08, 2026 -- Pulnovo Medical's pulmonary artery denervation (PADN) system reduced the risk of clinical worsening by 51% in patients with pulmonary hypertension linked to left heart disease (PH-LHD), according to results from the PADN-HF-PH trial presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The New England Journal of Medicine.

Washington – September 08, 2026 -- Independent testing commissioned by the Alliance to Prevent Legionnaires' Disease (APLD) found Legionella bacteria in 17 percent of 109 water samples collected from sinks, showers, hose bibs and other fixtures across the Upper East Side outbreak zone, results the group says expose gaps in New York City's current prevention strategy.

Boston – September 08, 2026 -- TraceLink has integrated its Drug Supply Chain Security Act (DSCSA) compliance solution with Omnicell, Inc. (Nasdaq: OMCL) pharmacy inventory management systems, embedding serialized product verification and traceability directly into hospital medication receiving workflows.

Rotterdam – September 08, 2026 -- United Imaging has secured CE Mark certification for the uCT SiriuX and uCT SiriuX Ultrix, clearing what the company calls the world's first dual wide-coverage computed tomography family for commercial sale across Europe.

Gothenburg – – September 07, 2026 -- Zinzino AB reported group revenue of SEK 282.2 million for August 2026, up 15% from SEK 245.9 million a year earlier, as growth in its direct-sales markets offset a sharp decline at subsidiary Faun Pharma.

Sales markets revenue climbs 16% to SEK 280.9 million in August

Zinzino's core direct-sales business generated SEK 280.9 million in August 2026, up from SEK 242.5 million in the same month last year, a 16% increase that drove the bulk of the group's top-line expansion.

Austin – September 07, 2026 -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has become the first facility in the United States to enroll in a clinical trial evaluating a next-generation mapping and pulsed field ablation (PFA) system for patients with paroxysmal and persistent atrial fibrillation.

Prague – September 07, 2026 -- BTL has formally established a dedicated laser division and confirmed the upcoming launch of EXOLASE ONE®, a system it describes as the first medical application of fused erbium laser technology, treating an entire face in under 10 minutes.

Prague – September 07, 2026 -- BTL has established a dedicated laser division and will launch its flagship EXOLASE ONE system, the first medical application of fused erbium laser technology, marking the company's sixth core business line.